https://www.selleckchem.com/pr....oducts/linderalacton
Furosemide was associated with reduced in-hospital mortality [hazard ratio (HR) 0.67; 95% CI 0.61-0.74; P less then 0.001] and 90-day mortality [HR 0.69; 95% CI 0.64-0.75; P less then 0.001], and it was also associated with the recovery of renal function [HR 1.44; 95% CI 1.31-1.57; P less then 0.001] in over-all AKI patients. Nevertheless, results illustrated that furosemide was not associated with reduced in-hospital mortality in patients with AKI stage 0-1 defined by UO criteria, AKI stage 2-3 according to SCr criteria, and
Like
Comment
Share
